CHARLES DAVIS: Open Payments
NPI 1952397564 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,847 in 125 payments from 46 companies in 2025. Trend: 2023 $3,363 · 2024 $3,271 · 2025 $2,847
Food & beverage: $2,847
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $366 |
| Merck Sharp & Dohme LLC | 10 | $226 |
| Gilead Sciences, Inc. | 9 | $217 |
| GlaxoSmithKline, LLC. | 7 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $146 |
| PFIZER INC. | 6 | $121 |
| ABBVIE INC. | 5 | $118 |
| SOBI, INC | 5 | $97 |
| JAZZ PHARMACEUTICALS INC. | 4 | $97 |
| BeOne Medicines USA, Inc. | 5 | $93 |
Products named: Trodelvy, KEYTRUDA, KISQALI, Nubeqa, Fabhalta, BRUKINSA, AYVAKIT, REBLOZYL.
Industry payments across GA — which companies pay providers there.
